Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Qualigen Therapeutics Inc (QLGN)

2.88   -0.02 (-0.69%) 03-07 04:36
Open: 2.96 Pre. Close: 2.9
High: 2.98 Low: 2.562
Volume: 1,621,303 Market Cap: 77M
Qualigen, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system; ALAN, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; AS1411 for treating viral-based infectious diseases; RAS-F3, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and STARS blood cleansing system, a DNA/RNA-based treatment device that removes tumor-produced compounds and viruses from a patient's blood. Qualigen, Inc. was founded in 1996 and is based in Carlsbad, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.984 - 3.005 3.005 - 3.021
Low: 2.512 - 2.537 2.537 - 2.556
Close: 2.842 - 2.879 2.879 - 2.908

Technical analysis

as of: 2021-03-05 5:12:24 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 4.34     One year: 5.18
Support: Support1: 2.56    Support2: 2.13
Resistance: Resistance1: 3.72    Resistance2: 4.43
Pivot: 3.57
Moving Average: MA(5): 3.14     MA(20): 3.69
MA(100): 3.67     MA(250): 5.29
MACD: MACD(12,26): -0.16     Signal(9): -0.04
Stochastic oscillator: %K(14,3): 7.48     %D(3): 7.95
RSI: RSI(14): 31.80
52-week: High: 19.75  Low: 2.56  Change(%): -68.0
Average Vol(K): 3-Month: 203873  10-Days: 116199

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
QLGN has closed above bottom band by 7.4%. Bollinger Bands are 72.8% wider than normal. The large width of the bands suggest high volatility as compared to QLGN's normal range. The bands have been in this wide range for 1 bars. This is a sign that the current trend might continue.

Headline News

Fri, 05 Mar 2021
The Daily Biotech Pulse: Fulgent's Big Quarter, Gilead Awaits FDA Decision, Apellis Winds Up COVID-19 Study - Yahoo Finance

Mon, 01 Mar 2021
Qualigen Therapeutics Secures Option to Negotiate License for G-Quadruplex Anti-Cancer Technology from UCL - GlobeNewswire

Wed, 10 Feb 2021
Does Qualigen Therapeutics Inc (QLGN) Have What it Takes to be in Your Portfolio? - InvestorsObserver

Tue, 09 Feb 2021
Is Qualigen Therapeutics Inc (QLGN) Stock Worth a Buy Tuesday? - InvestorsObserver

Mon, 08 Feb 2021
Should You Buy Qualigen Therapeutics Inc (QLGN) Stock on Monday? - InvestorsObserver

Wed, 27 Jan 2021
Should You Buy Qualigen Therapeutics Inc (QLGN) Stock? - InvestorsObserver

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Underperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Outperform Debt to Equity: Underperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 27
Shares Float (M) 21
% Held by Insiders 10.91
% Held by Institutions 3.12
Shares Short (K) 1,920
Shares Short P. Month (K) 1,750

Stock Financials

EPS Est This Year
EPS Est Next Year
Book Value (p.s.)
Profit Margin
Operating Margin -152.04
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth -30.3
Gross Profit (p.s.) 0.014
Sales Per Share 0.172
EBITDA (p.s.) -0.255
Qtrly Earnings Growth
Operating Cash Flow (M) -7
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio
PEG Ratio
Price to Book value
Price to Sales 16.76
Price to Cash Flow -11.26

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.